The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients Takeuchi Hidemi 1, 7 ;A. Uchida Haruhito 1, 2 ;Kakio Yuki 1 ;Okuyama.

Slides:

Advertisements

Similar presentations

Importance of Clinical Pharmacy service in Egypt's Hospitals

Advertisements

What is &what does an internist do? Internists are specialists / experts in adult ( teen years through old age) health care Prevent, find and treat illness.

2016 Annual Data Report, Vol 2, ESRD, Ch 5

A.M. Thompson, T.G. Pickering Kidney International

The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients Takeuchi Hidemi 1, 7 ;A. Uchida Haruhito 1, 2 ;Kakio Yuki 1 ;Okuyama.

Low Normal TSH levels are Associated with Impaired BMD and Hip Geometry in the Elderly Su Jin Lee 1, 2 ;Kyoung Min Kim 3 ;Eun Young Lee 4 ;Mi Kyung Song.

Low Normal TSH levels are Associated with Impaired BMD and Hip Geometry in the Elderly Su Jin Lee 1, 2 ;Kyoung Min Kim 3 ;Eun Young Lee 4 ;Mi Kyung Song.

Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program Cardiorenal Med 2011;1:45–52 - DOI: /

ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.

Mortality rates in incident ESRD patients figure 9

P2X 7 Receptor and APOE Polymorphisms and Survival from Heart Failure: A Prospective Study in Frail Patients in a Geriatric Unit Giuseppe Pasqualetti;Marta.

December 31st point prevalent counts by modality figure 3.1

Hospital admissions per patient, by modality figure 5

Nutrition and chronic kidney disease

Associations Between Low Serum Testosterone and All-Cause Mortality and Infection- Related Hospitalization in Male Hemodialysis Patients: A Prospective.

Beta blockers in the management of chronic kidney disease

Volume 67, Pages S1-S7 (June 2005)

Figure 1 The genomic nephrology workflow: genetic diagnosis and clinical application Figure 1 |The genomic nephrology workflow: genetic diagnosis and clinical.

Anemia management in chronic kidney disease

End-stage renal disease in developing countries

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Volume 66, Issue 4, Pages (October 2004)

CHAPTER 1 All Renal Replacement Therapy In Malaysia

Volume 80, Issue 1, Pages (July 2011)

Volume 75, Issue 11, Pages (June 2009)

Both cardiovascular and non-cardiovascular diseases are important causes of death in dialysis patients: A comparison with the general population Minako.

Insights From the 2016 Peer Kidney Care Initiative Report: Still a Ways to Go to Improve Care for Dialysis Patients James B. Wetmore, Suying Li, Julia.

Need for better diabetes treatment for improved renal outcome

Volume 88, Issue 2, Pages (August 2015)

Adjusted rate ratios of hospital days and admissions for blacks and Hispanics compared with whites by age group. Adjusted rate ratios of hospital days.

Volume 73, Issue 5, Pages (March 2008)

Anemia as a risk factor for chronic kidney disease

The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis Sai Subhodhini Reddy, Jean L. Holley

Nutrition and chronic kidney disease

Survival advantage in Asian American end-stage renal disease patients1

Stephen P. McDonald Kidney International Supplements

Volume 72, Issue 9, Pages (November 2007)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

Volume 75, Issue 1, Pages (January 2009)

Blood pressure targets in hemodialysis patients

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

Alternate-day dialysis may be needed for hemodialysis patients

Cardiovascular disease in pediatric chronic dialysis patients

Volume 76, Issue 1, Pages (July 2009)

The global challenge of chronic kidney disease

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 87, Issue 1, Pages (January 2015)

Volume 62, Issue 4, Pages (October 2002)

Volume 58, Issue 1, Pages (July 2000)

Hemodialysis patients represent a tiny subset of all patients with heart disease. Hemodialysis patients represent a tiny subset of all patients with heart.

Opportunities for a chronic disease outreach program in China

Current status of maintenance hemodialysis in Beijing, China

K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M

Volume 72, Issue 2, Pages (July 2007)

Volume 80, Issue 10, Pages (November 2011)

The Use of Vaccines in Adult Patients With Renal Disease

Volume 75, Issue 1, Pages (January 2009)

The hypothesis that abnormal BH4 metabolism impairs kidney function

Renal replacement therapy in Latin America

Recent developments in the management of secondary hyperparathyroidism

Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton

Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti

Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.

Antioxidant therapy in hemodialysis patients: a systematic review

Volume 87, Issue 6, Pages (June 2015)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.

Volume 68, Issue 4, Pages (October 2005)

Presentation transcript:

The Prevalence of Frailty and its Associated Factors in Japanese Hemodialysis Patients Takeuchi Hidemi 1, 7 ;A. Uchida Haruhito 1, 2 ;Kakio Yuki 1 ;Okuyama Yuka 1 ;Okuyama Michihiro 3 ;Umebayashi Ryoko 1 ;Wada Kentaro 4 ;Sugiyama Hitoshi 1, 5 ;Sugimoto Ken 6 ;Rakugi Hiromi 6 ;Wada Jun 1 ; 1 Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. ; 2 Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. ; 3 Department of Cardiovascular Surgery, Okayama University Hospital, Okayama, Japan. ; 4 Division of Nephrology and Dialysis, Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Hiroshima, Japan. ; 5 Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. ; 6 Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. ; 7 Department of Internal Medicine, Innoshima General Hospital, Hiroshima, Japan ; Figure 3. The Ratio of the Frailty Phenotypes according to the Duration of Dialysis and Age. The upper panel shows the ratio of the frailty phenotypes according to the duration of dialysis. The lower panel shows the ratio of the frailty phenotypes according to the age. null,null,0(0),1980-2015. Doi:10.14336/AD.2017.0429